tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Maneka Mirchandaney, 6 are a BUY (66.67%), 3 are a HOLD (33.33%).
Analyst Maneka Mirchandaney, carries an average stock price target met ratio of 43.33% that have a potential upside of 23.67% achieved within 174 days. Previously, Maneka Mirchandaney worked at EVERCORE.
Maneka Mirchandaney’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VRDN, Viridian Therapeutics at 15-May-2026.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for INKT (MINK THERAPEUTICS) at 11/9/2021. The price target of $30 was fulfilled within 76 days with a profit of $168 (84.85%) receiving and performance score of 11.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2019
$85
$0.31 (0.37%)
$81
Buy Since 07-Jul-2026
$85
$0.31 (0.37%)
Buy Since 30-Mar-2023
$85
$0.31 (0.37%)
$62
Buy Since 19-Mar-2024
$85
$0.31 (0.37%)
$85
Which stock is Maneka Mirchandaney is most bullish on?
Which stock is Maneka Mirchandaney is most reserved on?
What Year was the first public recommendation made by Maneka Mirchandaney?
